Equity

F&O

MF

Open an Account

Equity Analysis

Company Profile

MF Holdings

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

91.3566062

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

55.81

35471.08

EPS(TTM)

Face Value()

Div & Yield %:

37.52

10

1.53

As on: May 05, 2024 10:55 AM

Scheme Name	Inv Date	Amount Invested ( in Cr)	Net Assets(%)	Total NAV ( in Cr)
Aditya Birla SL ELSS Tax Saver Fund	31-Mar-24	227.14	1.52	14976.12
Nippon India Pharma Fund	31-Mar-24	166.22	2.33	7125.28
SBI Magnum Midcap Fund	31-Mar-24	157.07	0.93	16856.01
Kotak Equity Opportunities Fund	31-Mar-24	129.78	0.65	19861.46
Quant Mid Cap Fund	31-Mar-24	114.46	1.95	5873.25
Nippon India Growth Fund	31-Mar-24	108.81	0.44	24796.00
Aditya Birla SL MNC Fund	31-Mar-24	105.48	3.02	3491.79
Kotak Flexi Cap Fund	31-Mar-24	54.84	0.12	45911.90
Nippon India Small Cap Fund	31-Mar-24	44.52	0.10	45749.06
Quant Large and Mid Cap Fund	31-Mar-24	43.99	2.08	2110.44

1 2 3 4